Caption: Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Credit: Market Research Reports, Inc. Related Press Releases Global Diabetes and Obesity Therapeutics Market Will More Than Double to $163.2 Billion by 2022; Finds New Report Link to this Photo Email & IM: Direct Link: HTML Code: IMG Code: Download Photo High Resolution Screen Resolution Medium Resolution Small Resolution Thumbnail Resolution Download Photo Information Source: Market Research Reports, Inc. Release date: Wednesday Aug 31, 2016 Release time: 02:39 am Width:: 1213px Height:: 850px Size:: 219 KB Share